Urate lowering therapy for patients with gout on hemodialysis

被引：0
|
作者：
Alkilany, Reem [1 ,4 ]
Einstadter, Douglas [2 ,3 ]
Antonelli, Maria [1 ]
机构：
[1] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Med, Div Rheumatol, Cleveland, OH USA
[2] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Cleveland, OH USA
[3] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Internal Med, Cleveland, OH USA
[4] Dept Rheumatol, 2500 Metrohlth Dr, Haman Bldg, 5th Floor, Cleveland, OH 44109 USA
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2023年 / 26卷 / 03期
关键词：
ESRD; gout; hemodialysis; uric acid;
D O I：
10.1111/1756-185X.14527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：585 / 585
页数：1
相关论文
共 50 条
  • [31] Diet May Be the Most Relevant Feature for the Success of Urate Lowering Therapy in Gout
    Kalkan, Nimet Bilge
    Tezcan, Mehmet Engin
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2020, 37 (03) : 286 - 293
  • [32] Prophylaxis for acute gout flares after initiation of urate-lowering therapy
    Latourte, Augustin
    Bardin, Thomas
    Richette, Pascal
    RHEUMATOLOGY, 2014, 53 (11) : 1920 - 1926
  • [33] Urate-Lowering Therapy for the Management of Gout: Summary of 2 Cochrane Reviews
    Kydd, Alison S.
    Seth, Rakhi
    Buchbinder, Rachelle
    Falzon, Louise
    Edwards, Christopher J.
    van der Heijde, Desiree M.
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2014, 41 : 33 - 41
  • [34] The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
    Pang, Lei
    Xue, Xiaomei
    He, Yuwei
    Wang, Can
    Han, Lin
    Li, Maichao
    Qi, Han
    Li, Changgui
    Lu, Jie
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 3937 - 3947
  • [35] Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
    C. A. Janssen
    M. A. H. Oude Voshaar
    P. M. ten Klooster
    H. E. Vonkeman
    M. A. F. J. van de Laar
    Clinical Rheumatology, 2019, 38 : 2233 - 2239
  • [36] Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
    Liu, Ching-Han
    Huang, Shih-Chung
    Yin, Chun-Hao
    Huang, Wei-Chun
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Gan, Su-Ting
    Tzou, Shiow-Jyu
    Hsu, Ching-Tsai
    Wu, Hao-Ming
    Wang, Wen-Hwa
    BIOMEDICINES, 2023, 11 (01)
  • [37] Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy
    Tsutsumi, Z
    Moriwaki, Y
    Takahashi, S
    Ka, T
    Yamamoto, T
    CLINICA CHIMICA ACTA, 2004, 339 (1-2) : 117 - 122
  • [38] Urate-lowering treatment and risk of total joint replacement in patients with gout
    Kuo, Chang-Fu
    Chou, I-Jun
    See, Lai-Chu
    Chen, Jung-Sheng
    Yu, Kuang-Hui
    Luo, Shue-Fen
    Hsieh, Ao-Ho
    Zhang, Weiya
    Doherty, Michael
    RHEUMATOLOGY, 2018, 57 (12) : 2129 - 2139
  • [39] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [40] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Robert L Jackson
    Barbara Hunt
    Patricia A MacDonald
    BMC Geriatrics, 12
12345